Hall A V, Johnson J D, Stevens P J, Renton N E, Holliman R E
Public Health Laboratory Service, St. George's Hospital, London.
J Med Microbiol. 1993 Jan;38(1):34-7. doi: 10.1099/00222615-38-1-34.
The microparticle capture enzyme immuno-assay (MEIA) is an automated system for measuring specific antibody by interaction with antigen-coated particles. An MEIA method for detecting toxoplasma-specific IgM was compared with established reference methods. The MEIA had an acceptable level of sensitivity and reproducibility and was easier to perform than conventional tests, but it required expensive, dedicated equipment and, in our study, false positive results were recorded with 7% of samples. MEIA could be used to investigate immunocompetent patients with suspected toxoplasmosis but positive findings should be confirmed by an alternative form of assay. The technique is not suitable for the investigation of neonates, for which a more sensitive method is required.
微粒捕获酶免疫测定法(MEIA)是一种通过与抗原包被颗粒相互作用来测量特异性抗体的自动化系统。将一种检测弓形虫特异性IgM的MEIA方法与既定的参考方法进行了比较。MEIA具有可接受的灵敏度和重现性水平,且比传统检测方法更易于操作,但它需要昂贵的专用设备,并且在我们的研究中,7%的样本出现了假阳性结果。MEIA可用于对疑似弓形虫病的免疫功能正常患者进行检测,但阳性结果应以另一种检测形式进行确认。该技术不适用于新生儿检测,因为需要更灵敏的方法。